Sectors:
Min Investment:
Max Investment:
Target Investment:
(1980 - 1985)
2021
2023
2021 - 2023
DCVC backs brilliant entrepreneurs applying Deep Tech, from the earliest stage and beyond, to pragmatically and cost-effectively tackle previously unsolvable problems in nearly every industry.
2023
Kanvas's novel spatial biology platform enables an unprecedented understanding of host-microbiome interaction and provides an efficient approach to drug discovery for live biological products.
2023
2023
Recycleye sells AI robotics and computer vision technologies for innovative waste and materials management.
2023
Aquafortus was founded in New Zealand to develop and commercialize a novel and proprietary zero liquid discharge technology that can treat high salinity wastewater at a fraction of the cost of current processes.
2022
2022
DVLP is building a new infrastructure for drug development on the blockchain. By digitizing drug assets, financing, and development workflows, we are reimagining and accelerating the entire process to turn more molecules into medicines.
2022
Relation is pioneering a “Lab-in-the-Loop” that can integrate active learning at every step of drug discovery, from predicting cell states to the validation of new targets.
2022
2022
ZwitterCo's zwitterionic membranes can handle unprecedented levels of oil and grease without irreversible fouling, recovering full performance.
2021
2021
A breakthrough technology for continuous health monitoring, more than a decade in development at Helmholtz Institute and Caltech, now in commercial development, which will allow people to be better stewards of their own health.
2021
2021
Evonetix is reimagining biology by developing a radically different approach to gene synthesis – a highly parallel desktop platform to synthesize DNA at unprecedented accuracy, scale and speed. The company's platform will place DNA synthesis in the hands of every researcher and change how DNA is accessed, made, and used—a new paradigm for gene synthesis.
2019
2019
Applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.